Product code NCX— Cardiovascular

REPRIEVE ENDOVASCULAR TEMPERATURE THERAPY SYSTEM

Classification name
System, Hypothermia, Intravenous, Cooling
Device class
Class 2
Regulation
21 CFR 870.5900
Advisory panel
Cardiovascular
Total cleared
26
First cleared
Most recent

Market context for product code NCX

FDA has cleared 26 devices under product code NCX between 2002 and 2023, filed by 10 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code NCX

Adverse events under product code NCX

product code NCX
Death
30
Malfunction
2,302
Total
2,332

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recent clearances under product code NCX

Data sourced from openFDA. This site is unofficial and independent of the FDA.